# Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

> **NCT00994344** · PHASE4 · COMPLETED · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 73 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Darunavir/ritonavir
- **DRUG:** Lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00994344
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00994344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00994344, "Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00994344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*